C07D 243/08
Not condensed with other rings
Official title: not condensed with other rings
C07D243/08 (Not condensed with other rings) appears on 435 US grants and 442 published applications in this corpus.
Search patents in C07D- Granted patents
- 435
- Published applications
- 442
- Assignees
- 274
- Inventors
- 1,584
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 4 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 4 | 0 |
| 1988 | 10 | 0 |
| 1989 | 4 | 0 |
| 1990 | 5 | 0 |
| 1991 | 7 | 0 |
| 1992 | 5 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 8 | 0 |
| 2001 | 6 | 2 |
| 2002 | 17 | 15 |
| 2003 | 15 | 22 |
| 2004 | 15 | 27 |
| 2005 | 13 | 23 |
| 2006 | 14 | 28 |
| 2007 | 16 | 26 |
| 2008 | 14 | 30 |
| 2009 | 18 | 26 |
| 2010 | 27 | 33 |
| 2011 | 18 | 26 |
| 2012 | 17 | 16 |
| 2013 | 26 | 15 |
| 2014 | 11 | 11 |
| 2015 | 16 | 18 |
| 2016 | 8 | 13 |
| 2017 | 14 | 13 |
| 2018 | 10 | 13 |
| 2019 | 8 | 11 |
| 2020 | 8 | 15 |
| 2021 | 7 | 11 |
| 2022 | 6 | 9 |
| 2023 | 12 | 14 |
| 2024 | 4 | 7 |
| 2025 | 6 | 13 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- Methods and compositions for targeting Tregs using CCR8 inhibitors17 Feb 2026US 12,552,753 B2Nanjing Immunophage Biomedical Co., Ltd.
- Compound as voltage-gated sodium channel inhibitor13 Jan 2026US 12,521,399 B2Guangzhou Fermion Technology Co., Ltd.
- Small molecules for cancer therapy that reduce the expression of transcription factors KLF5 and EGR-12 Dec 2025US 12,486,227 B2The Research Foundation for The State University of New York
- Compound as voltage-gated sodium channel inhibitor3 Sep 2026US 2026/0257996 A1Guangzhou Fermion Technology Co., Ltd.
- Therapeutic compounds and compositions13 Aug 2026US 2026/0234110 A1Agios Pharmaceuticals, Inc.
- Cationic lipids and preparation method thereof16 Jul 2026US 2026/0200849 A1RiboX Therapeutics HK Limited
- Pi3k-alpha inhibitors and methods of use thereof5 Feb 2026US 2026/0035335 A1Relay Therapeutics, Inc.
- Nanomaterials1 Jan 2026US 2026/0001838 A1Guide Therapeutics, LLC
Most cited
By later US patents
- Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof83US 6,441,172 B1Torrey Pines Institute for Molecular Studies · 2002
- Selective estrogen receptor modulator79US 7,612,114 B2Eisai R&D Management Co., Ltd. · 2009
- Amine-containing lipids and uses thereof69US 9,006,487 B2Massachusetts Institute of Technology · 2015
- Hexahydro-5-imino-1,4-1,4-thiazepine derivatives as inhibitors of nitric oxide synthases64US 6,372,733 B1Merck & Co., Inc. · 2002
- Sulfonamide derivatives and drugs containing the same as the active ingredient62US 6,403,607 B12002